United European Gastroenterology Journal

Article	Citations
Liver injury in COVID‐19: The current evidence	176
European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations	125
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations	117
European guidelines on chronic mesenteric ischaemia – joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal a	97
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis	85
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group	68
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutri	66
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	62
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia	57
Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta‐analysis	49
Pancreatic cancer‐derived organoids – a disease modeling tool to predict drug response	46
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility	45
European guideline on indications, performance and clinical impact of 13C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC	44
European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice	42
Non‐alcoholic fatty liver disease increases the risk of incident chronic kidney disease	41
A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease	40
Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden	40
Pancreatic tuberculosis: A systematic review of symptoms, diagnosis and treatment	39
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study	35
Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation	35
Implications of the changing epidemiology of inflammatory bowel disease in a changing world	35
Impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammatory bowel disease ce	34
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases	33
New concepts in the treatment of hepatocellular carcinoma	33
The daily impact of COVID‐19 in gastroenterology	33

Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study	32
Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration	31
The gastrointestinal tract in hunger and satiety signalling	30
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease	29
Gut fermentation syndrome: A systematic review of case reports	28
Environmental risk factors for inflammatory bowel disease	28
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better	26
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency	25
The microbiome in pancreatic diseases: Recent advances and future perspectives	25
SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease	25
Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study	25
Time trends in incidence and prevalence of chronic pancreatitis: A 25‐year population‐based nationwide study	24
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study	24
Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials	23
The global prevalence of Barrett’s esophagus: A systematic review of the published literature	23
Effectiveness and safety of vedolizumab in biologically naïve patients: A real‐world multi‐centre study	22
Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register	22
Colon capsule endoscopy versus CT colonography after incomplete colonoscopy. Application of artificial intelligence algorithms to identify complete colonic investigations	22
Current status and limitations of artificial intelligence in colonoscopy	22
A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education ‐ a population‐based cross‐sectional study of incidence, diagnostic process and complications of eosinophilic oesophagi	22
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure	22
Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease	21
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies	21
Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience	21
Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases	21
Patterns of liver injury in COVID‐19 – a German case series	20
Clinical management of patients with drug‐induced liver injury (DILI)	20
Diagnosis and treatment of primary biliary cholangitis	20
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries	20
Genomic and molecular alterations in human inflammatory bowel disease‐associated colorectal cancer	20
Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on	20
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis	20
A new artificial intelligence system successfully detects and localises early neoplasia in Barrett's esophagus by using convolutional neural networks	19
Long‐term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort	19
Clinical management of the most common extra‐intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes	19
Endoscopic ultrasound‐based multimodal evaluation of the pancreas in patients with suspected early chronic pancreatitis	19
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018	19
The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study	18
Management of pregnancy in women with cirrhosis	18
Analysis of the burden and economic impact of digestive diseases and investigation of research gaps and priorities in the field of digestive health in the European Region—White Book 2: Executive summa	18
Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry	18
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline	18
Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland	18
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn’s disease	18
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population	17
COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology	17
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020	17
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease	16
Rising incidence of acute pancreatitis in Sweden: National estimates and trends between 1990 and 2013	16
Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis	16

Treat‐to‐target and sequencing therapies in Crohn's disease	15
Ultrasonography in inflammatory bowel disease – So far we are?	15
Gastrointestinal bleeding and endoscopic findings in critically and non‐critically ill patients with corona virus disease 2019 (COVID‐19): Results from Lean European Open Survey on SARS‐CoV‐2 (LEOSS)	15
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study	15
Towards evidence‐based and personalised care of acute pancreatitis	15
Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study	15
The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth	15
Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?	15
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis	15
Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis	15
Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer	15
Gastroesophageal reflux after per‐oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: A case‐control study	15
Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study	14
Suboptimal care for chronic pancreatitis patients revealed by moderate to low adherence to the United European Gastroenterology evidence‐based guidelines (HaPanEU): A Netherlands nationwide analysis	14
Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022	14
Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review	14
Cold versus hot polypectomy/endoscopic mucosal resection–A review of current evidence	14
Antimicrobial therapy of 3 days or less is sufficient after successful ERCP for acute cholangitis	14
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease	14
Functional dyspepsia is associated with lower exercise levels: A population‐based study	13
Endoscopy works during the pandemic of coronavirus COVID‐19: recommendations by the Chinese Society of Digestive Endoscopy	13
Real‐time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome—A randomized controlled pilot trial (CADLY)	13
Clinical management of type C hepatic encephalopathy	13
Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance	13
Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community‐based cohort study	13
Cold snare polypectomy for large sessile serrated lesions is safe but follow‐up is needed: a single‐centre retrospective study	13
Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT‐TOPIC trial after 1‐year follow‐up	13
Tumour‐stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case‐cohort study	13
Mortality in acute pancreatitis with persistent organ failure is determined by the number, type, and sequence of organ systems affected	13
Wound healing of metastatic perineal Crohn’s disease using hyperbaric oxygen therapy: A case series	13
Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease	12
Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population	12
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme	12
Histologic parameter score does not predict short‐term survival in severe alcoholic hepatitis	12
UEG Week 2021 Poster Presentations	12
Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study	12
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study	12
How to raise the interest for neurogastroenterology among young gastroenterologists?	12
Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments	12
Endoscopic band ligation compared to thermal therapy for gastric antral vascular ectasia: A systematic review and meta‐analysis	12
Proximal retroflexion versus second forward view of the right colon during screening colonoscopy: A multicentre randomized controlled trial	12
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision‐making programme using decision tables	12
Tips from the battlefront: Psychological support of patients with a chronic illness during the COVID‐19 lockdown in four steps	12
Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate	12
Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites	12
Landscape of new drugs and targets in inflammatory bowel disease	12
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization	12
Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis	12
Is tofacitinib a game‐changing drug for ulcerative colitis?	11
Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature	11
Post‐polypectomy surveillance colonoscopy: Comparison of the updated guidelines	11
Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy	11
Development and evaluation of a deep learning model to improve the usability of polyp detection systems during interventions	11
Sample‐size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review	11
Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study	11
Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression	11
Diagnostic accuracy of pan‐enteric capsule endoscopy and magnetic resonance enterocolonography in suspected Crohn's disease	10
Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls	10
Immunoglobulin G subtypes‐1 and 2 differentiate immunoglobulin G4‐associated sclerosing cholangitis from primary sclerosing cholangitis	10
Albumin: Indications in chronic liver disease	10
High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort	10
A starch‐ and sucrose‐reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence varian	10
High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong	10
Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors	10
Probe‐based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist‐blinded study	10
Standard versus Endocuff versus cap‐assisted colonoscopy for adenoma detection: A randomised controlled clinical trial	10
UEG Week 2020 Oral Presentations	9
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication thera	9
New endoscopic tools in inflammatory bowel disease	9
Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study	9
Endoscopic retrograde cholangiopancreatography‐related adverse events in Korea: A nationwide assessment	9
Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education	9
COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry	9
Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry	9
Endoscopic treatment with transmural drainage and necrosectomy for walled‐off necrosis provides favourable long‐term outcomes on pancreatic function	9
Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1	9
Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?	9
Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double‐blind, placebo‐controlled trial	9
Oral health and salivary function in ulcerative colitis patients	9
German guideline diverticular disease/diverticulitis	9

Young GI angle #Twitter2Paper: Taking an idea from Twitter to paper	9
Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study	9
Crohn's disease related strictures in cross‐sectional imaging: More than meets the eye?	9
Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey	9
Adverse events in endoscopic retrograde cholangiopancreaticography (ERCP): Focus on post‐ERCP‐pancreatitis	8
Serum phosphate is associated with mortality among patients admitted to ICU for acute pancreatitis	8
Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study	8
UEG framework for the development of high‐quality clinical guidelines	8
Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review	8
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	8
High prevalence of ulcerative appendicitis in patients with ulcerative colitis	8
Glucose variability during the early course of acute pancreatitis predicts two‐year probability of new‐onset diabetes: A prospective longitudinal cohort study	8
Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases	8
Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany	8
Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease	8
Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications	8
Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease	8
The COlorectal NEoplasia Endoscopic Classification to Choose the Treatment classification for identification of large laterally spreading lesions lacking submucosal carcinomas: A prospective study of	8
AGREE‐S: AGREE II extension for surgical interventions – United European Gastroenterology and European Association for Endoscopic Surgery methodological guide	8
Impact of therapies on bowel damage in Crohn’s disease	8
Endoscopists performance in optical diagnosis of colorectal polyps in artificial intelligence studies	8
Join the myUEG community and become an official myUEG Associate for free	8
Over‐the‐scope clip versus transcatheter arterial embolization for refractory peptic ulcer bleeding—A propensity score matched analysis	8
How to identify, encourage, and support suitable candidates for leading roles in scientific societies: The UEG experience	8